US to start distributing experimental virus drug

Covid-19

US to start distributing experimental virus drug

Monday, November 23, 2020

Print this page Email A Friend!


WASHINGTON, United States (AP) — The US government on Tuesday will start distributing 30,000 doses of an experimental antibody drug to fight COVID-19, the one President Donald Trump received last month.

Over the weekend, the Food and Drug Administration agreed to allow emergency use of the drug, made by Regeneron Pharmaceuticals Incorporation, for people with mild to moderate symptoms who are at high risk of developing serious illness because of their age or other medical conditions. It’s not authorised for use in sicker, hospitalised patients or those who need extra oxygen.

Antibodies bind to the virus and help the immune system eliminate it. The Regeneron drug is a combo of two antibodies that seemed to do this well in lab tests.

The emergency authorisation allows limited use of a drug while studies continue to test its safety and effectiveness. Early results suggest it may reduce COVID-19-related hospitalisation or emergency room visits.

The drugs are given as a one-time treatment through an IV. Under federal contracts, the drugs for now will be supplied for free, although patients may have to pay part of the cost of the IV treatment.


Now you can read the Jamaica Observer ePaper anytime, anywhere. The Jamaica Observer ePaper is available to you at home or at work, and is the same edition as the printed copy available at http://bit.ly/epaper-login


ADVERTISEMENT




POST A COMMENT

HOUSE RULES

1. We welcome reader comments on the top stories of the day. Some comments may be republished on the website or in the newspaper � email addresses will not be published.

2. Please understand that comments are moderated and it is not always possible to publish all that have been submitted. We will, however, try to publish comments that are representative of all received.

3. We ask that comments are civil and free of libellous or hateful material. Also please stick to the topic under discussion.

4. Please do not write in block capitals since this makes your comment hard to read.

5. Please don't use the comments to advertise. However, our advertising department can be more than accommodating if emailed: advertising@jamaicaobserver.com.

6. If readers wish to report offensive comments, suggest a correction or share a story then please email: community@jamaicaobserver.com.

7. Lastly, read our Terms and Conditions and Privacy Policy



comments powered by Disqus
ADVERTISEMENT

Poll

ADVERTISEMENT
ADVERTISEMENT

Today's Cartoon

Click image to view full size editorial cartoon
ADVERTISEMENT